FdaApplication
NDA 201922
Identifiers
- fda_app_no: NDA201922
Properties
| Property | Value |
|---|---|
| applicant_name | JOURNEY MEDICAL CORP |
| application_type | NDA |
| approval_date | 2012-07-11 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| XIMINO | MINOCYCLINE HYDROCHLORIDE | EQ 135MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| XIMINO | MINOCYCLINE HYDROCHLORIDE | EQ 112.5MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| XIMINO | MINOCYCLINE HYDROCHLORIDE | EQ 45MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| XIMINO | MINOCYCLINE HYDROCHLORIDE | EQ 67.5MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
| XIMINO | MINOCYCLINE HYDROCHLORIDE | EQ 90MG BASE | CAPSULE, EXTENDED RELEASE;ORAL |
5 products